Phase 1b/2 Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Previously Treated Unresectable Advanced or Metastatic Sarcomas (EMBOLD Sarcoma‑202)

Principal Investigator

Dr Sarah Pratap

Contact us

Email: latephaseoncology@ouh.nhs.uk

IRAS number

1013853